Related references
Note: Only part of the references are listed.Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease
Bernard J. Hanseeuw et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects
Ulf Neumann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition
Ann D. Cohen et al.
ALZHEIMERS & DEMENTIA (2018)
Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis
Angie C. A. Chiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Modulation of gamma- and beta-Secretases as Early Prevention Against Alzheimer's Disease
Iryna Voytyuk et al.
BIOLOGICAL PSYCHIATRY (2018)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers
Una Smailovic et al.
NEUROBIOLOGY OF AGING (2018)
Istradefylline reduces memory deficits in aging mice with amyloid pathology
Anna G. Orr et al.
NEUROBIOLOGY OF DISEASE (2018)
Neuronal Neuronal levels and sequence of tau modulate the power of brain rhythms
Melanie Das et al.
NEUROBIOLOGY OF DISEASE (2018)
Alzheimer's Disease: From Firing Instability to Homeostasis Network Collapse
Samuel Frere et al.
NEURON (2018)
Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a MouseModel of Alzheimer's Disease
Magdalena Martinez-Losa et al.
NEURON (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ
Kimberly Young et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
EEG oscillations during word processing predict MCI conversion to Alzheimer's disease
Ali Mazaheri et al.
NEUROIMAGE-CLINICAL (2018)
Somatic APP gene recombination in Alzheimer's disease and normal neurons
Ming-Hsiang Lee et al.
NATURE (2018)
Klotho controls the brain-immune system interface in the choroid plexus
Lei Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Decoding the synaptic dysfunction of bioactive human AD brain soluble A to inspire novel therapeutic avenues for Alzheimer's disease
Shaomin Li et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
Absence seizure susceptibility correlates with pre-ictal β oscillations
Jordan M. Sorokin et al.
JOURNAL OF PHYSIOLOGY-PARIS (2017)
Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity
Andras Horvath et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP
Zemin Wang et al.
JOURNAL OF NEUROSCIENCE (2017)
Practical considerations for choosing a mouse model of Alzheimer's disease
Joanna L. Jankowsky et al.
MOLECULAR NEURODEGENERATION (2017)
Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease
Alice D. Lam et al.
NATURE MEDICINE (2017)
Epigenetic suppression of hippocampal calbindin-D28k by ΔFosB drives seizure-related cognitive deficits
Jason C. You et al.
NATURE MEDICINE (2017)
Bidirectional Control of Generalized Epilepsy Networks via Rapid Real-Time Switching of Firing Mode
Jordan M. Sorokin et al.
NEURON (2017)
BACE inhibition-dependent repair of Alzheimer's pathophysiology
Aylin D. Keskin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Navβ2 knockdown improves cognition in APP/PS1 mice by partially inhibiting seizures and APP amyloid processing
Tao Hu et al.
ONCOTARGET (2017)
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
Helene-Marie Lanoiselee et al.
PLOS MEDICINE (2017)
Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease
Valentine Hamm et al.
SCIENCE ADVANCES (2017)
The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Randall J. Bateman et al.
ALZHEIMERS & DEMENTIA (2017)
Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease
S. Kim et al.
MOLECULAR PSYCHIATRY (2016)
Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology
Inger Lauritzen et al.
ACTA NEUROPATHOLOGICA (2016)
Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease
Keith A. Vossel et al.
ANNALS OF NEUROLOGY (2016)
Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss
Sachin Suresh Tiwari et al.
BRAIN (2016)
Ion channel regulation by -secretase BACE1-enzymatic and non-enzymatic effects beyond Alzheimer's disease
Sandra Lehnert et al.
CHANNELS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice
Sumihiro Maeda et al.
EMBO REPORTS (2016)
Cross-species translation of the Morris maze for Alzheimer's disease
Katherine L. Possin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Network abnormalities and interneuron dysfunction in Alzheimer disease
Jorge J. Palop et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease
Anupam Hazra et al.
NEUROBIOLOGY OF AGING (2016)
Cognitive deficits in single App knock-in mouse models
Akira Masuda et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
Seizures in dominantly inherited Alzheimer disease
Aline Zarea et al.
NEUROLOGY (2016)
Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia
Magdalena Przybyla et al.
NEUROSCIENCE LETTERS (2016)
Interictal spikes during sleep are an early defect in the Tg2576 mouse model of β-amyloid neuropathology
Korey Kam et al.
SCIENTIFIC REPORTS (2016)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
Ulf Neumann et al.
MOLECULAR NEURODEGENERATION (2015)
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Michael Willem et al.
NATURE (2015)
Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2015)
Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains
Christopher Janus et al.
NEUROBIOLOGY OF AGING (2015)
Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice
Alexandra J. Mably et al.
NEUROBIOLOGY OF DISEASE (2015)
Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
Alfred T. Welzel et al.
BIOCHEMISTRY (2014)
Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease
Stephanie W. Fowler et al.
JOURNAL OF NEUROSCIENCE (2014)
Genetic Suppression of Transgenic APP Rescues Hypersynchronous Network Activity in a Mouse Model of Alzeimer's Disease
Heather A. Born et al.
JOURNAL OF NEUROSCIENCE (2014)
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito et al.
NATURE NEUROSCIENCE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
Marta Pera et al.
ACTA NEUROPATHOLOGICA (2013)
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
Ting Yang et al.
ALZHEIMERS & DEMENTIA (2013)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
Brain amyloid-β oligomers in ageing and Alzheimer's disease
Sylvain E. Lesne et al.
BRAIN (2013)
Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease
Shuko Takeda et al.
FASEB JOURNAL (2013)
Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis
Tatiana Melnikova et al.
JOURNAL OF NEUROSCIENCE (2013)
Sodium Channel Cleavage Is Associated with Aberrant Neuronal Activity and Cognitive Deficits in a Mouse Model of Alzheimer's Disease
Brian F. Corbett et al.
JOURNAL OF NEUROSCIENCE (2013)
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
Linghua Qiu et al.
MOLECULAR NEURODEGENERATION (2013)
Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury
Jeanne T. Paz et al.
NATURE NEUROSCIENCE (2013)
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M. Roe et al.
NEUROLOGY (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
Luke A. Miles et al.
SCIENTIFIC REPORTS (2013)
Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
Scott J. Webster et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Keith A. Vossel et al.
JAMA NEUROLOGY (2013)
The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain
Jessica M. McDonald et al.
BRAIN RESEARCH (2012)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model
Laure Verret et al.
CELL (2012)
Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult
Shaefali P. Rodgers et al.
MOLECULAR NEURODEGENERATION (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
β-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice
Wan-Pin Chang et al.
FASEB JOURNAL (2011)
Reduced Sodium Channel Nav1.1 Levels in BACE1-null Mice
Doo Yeon Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
A new mode of corticothalamic transmission revealed in the Gria4-/- model of absence epilepsy
Jeanne T. Paz et al.
NATURE NEUROSCIENCE (2011)
Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain
D. L. Vogt et al.
NEUROBIOLOGY OF AGING (2011)
A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
Hiroaki Fukumoto et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
Brian O'Nuallain et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Rimante Minkeviciene et al.
JOURNAL OF NEUROSCIENCE (2009)
Zinc Finger Protein Zbtb20 Is Essential for Postnatal Survival and Glucose Homeostasis
Andrew P. R. Sutherland et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life
Ganesh M. Shankar et al.
NEUROBIOLOGY OF DISEASE (2009)
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels
Ana-Maria Simon et al.
NEUROBIOLOGY OF DISEASE (2009)
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage
A. Rovelet-Lecrux et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models
Irene H. Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Thalamic synchrony and dynamic regulation of global forebrain oscillations
John R. Huguenard et al.
TRENDS IN NEUROSCIENCES (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
The Arctic Alzheimer mutation favors intracellular amyloid-β production by making amyloid precursor protein less available to α-secretase
Charlotte Sahlin et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Activity of ventral medial thalamic neurons during absence seizures and modulation of cortical paroxysms by the nigrothalamic pathway
Jeanne Tamar Paz et al.
JOURNAL OF NEUROSCIENCE (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Alterations of behavior and spatial learning after unilateral entorhinal ablation of rats
Z Kopniczky et al.
LIFE SCIENCES (2006)
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
A Rovelet-Lecrux et al.
NATURE GENETICS (2006)
Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease
JL Jankowsky et al.
PLOS MEDICINE (2005)
Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice
JJ Palop et al.
JOURNAL OF NEUROSCIENCE (2005)
Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation
DM Walsh et al.
JOURNAL OF NEUROSCIENCE (2005)
Cellular and network mechanisms of spike-wave seizures
H Blumenfeld
EPILEPSIA (2005)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation
IH Cheng et al.
NATURE MEDICINE (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits
JJ Palop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Alzheimer disease γ-secretase:: a complex story of GxGD-type presenilin proteases
C Haass et al.
TRENDS IN CELL BIOLOGY (2002)
The Arctic mutation interferes with processing of the amyloid precursor protein
C Stenh et al.
NEUROREPORT (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
MP Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
New spatial cognition tests for mice: Passive place avoidance on stable and active place avoidance on rotating arenas
JM Cimadevilla et al.
BRAIN RESEARCH BULLETIN (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Astroglial expression of human α1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
L Mucke et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments
Y Fezoui et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice:: Synaptotoxicity without plaque formation
L Mucke et al.
JOURNAL OF NEUROSCIENCE (2000)